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Abstract  
Objectives: Whether tick-borne infections can cause chronic subjective health complaints is heavily debated.  
If such a causal connection exists, one would expect to find more health complaints among individuals exposed 
to tick-borne infections than among non-exposed. In this study, we aimed to assess if exposure to tick-borne 
infections earlier in life, evaluated by examination of serum for IgG-antibodies to tick-borne microbes, was 
associated with self-reported somatic symptom load. 
Materials & Methods: All individuals with residential address in Søgne municipality in southern Norway, aged 
18-69 years, were invited to participate in the study. Blood samples were analyzed for IgG-antibodies to 
different tick-borne microbes, and somatic symptom load was charted by the Patient Health Questionnaire-15 
(PHQ-15).   
Results: Out of 7424 invited individuals, 2968 (40.0%) were included in the study. We detected IgG-antibodies 
to Borrelia burgdorferi sensu lato (Bb) in 22.9% (95% CI 21.4 - 24.4). Bb seropositive individuals reported less 
frequently moderate to severe somatic symptom load (i.e. PHQ-15 sum score >10) than seronegative individuals 
(12.5% versus 17.7%, difference 5.2% (95% 2.1 - 8.0)). However, when adjusting for several other variables in a 
multivariable linear regression model, presence of serum IgG-antibodies to Bb was not associated with somatic 
symptom load. Presence of IgG-antibodies to other tick-borne microbes than Bb, or seropositivity to at least two 
microbes, were also not associated with somatic symptom load. 
Conclusion: Presence of serum IgG-antibodies to tick-borne microbes was not associated with self-reported 
somatic symptom load. 
Keywords: 
Tick-borne diseases, Lyme borreliosis, seroepidemiologic studies, diagnostic self-evaluation, PHQ, medically 
unexplained symptoms  
 
Introduction 
Subjective symptoms for which doctors cannot find a medical explanation, often termed “subjective health 
complaints” or “medically unexplained symptoms”, represent a global health challenge 1. The most common 
symptoms are fatigue, musculoskeletal pain, headache, gastrointestinal discomfort and dizziness. Such 
symptoms are frequently reported in European population studies 2-4, are frequent causes of consultations both in 
primary and secondary health care services 5,6, and are major causes of sick-leave and disability 1. In several 
countries in northern Europe, the prevalence of medically unexplained symptoms has been reported to be up to 
30% among patients referred to neurological outpatient clinics 7.   
 
Patients with medically unexplained symptoms are often worried about undetected underlying disease despite 
thorough examination, and continue to search for a potential cause and treatment. Over the past years tick-borne 
diseases as borreliosis has been launched as a possible cause of chronic subjective health complaints, and many 
want long-term antibiotic treatment despite evidence of no effect 8. It has also been claimed that tick-borne 
diseases can trigger other neurological disorders, but also for this hypothesis evidence is lacking 9.  
 
The tick Ixodes ricinus is widespread along the coastline in southern Norway 10, and borreliosis caused by 
Borrelia burgdorferi sensu lato (Bb) is the most common tick-borne disease 11. A Bb infection can be 
asymptomatic, present as a local skin infection, or cause diseases as neuroborreliosis or borrelia arthritis. 
Furthermore, several “emerging” tick-borne pathogens (Anaplasma, Babesia, Bartonella, Neoehrlichia and 
Rickettsia) have been detected in ticks in northern Europe the last decades 12-15, but the knowledge about the 
human prevalence and clinical impact of these infections is still scarce. The clinical impact of simultaneous 
infections with more than one tick-borne pathogen is also largely unknown. 
 
Exposure to tick-borne infections earlier in life can be charted retrospectively by examination of serum samples 
for presence of IgG-antibodies to specific microbes. If the hypothesis claiming a causal connection between tick-
borne infections and subjective health complaints is correct, one would expect the group exposed to tick-borne 
infections earlier in life to have more health complaints than the non-exposed group. The aim of our study was to 
assess if presence of serum IgG-antibodies to tick-borne microbes was associated with increased self-reported 
somatic symptom load in a Norwegian population with high exposure to ticks.  
 
Materials & Methods  
 
Recruitment area  
Søgne is a coastal area in Agder county, in the southernmost part of Norway. Søgne has a high abundance of 
ticks 10, and a high incidence of neuroborreliosis 16. In January 2016, there was 11260 inhabitants in Søgne, of 
whom 7424 were aged from 18 to 69 years.  
 
Recruitment strategies 
We invited all individuals aged 18-69 years, with residential address in Søgne municipality, to participate in the 
study. Two different recruitment strategies were used: From June 2015 to January 2016, eligible individuals who 
attended the general practitioner’s center were invited to participate. Then, from January to June 2016, we sent 
an invitation letter to all eligible individuals not already enrolled in the study. Participants who did not respond 
to the questionnaire within 2-6 weeks after blood sampling were contacted once more by letter or phone for a 
reminder. Further details on the recruitment procedure have been published previously 4.  
 
Serological tests 
Enzyme-linked immunosorbent assay (ELISA) tests were applied for detection of serum IgG antibodies to Bb 
and Tick-borne encephalitis virus. Indirect immunofluorescent assay (IFA) tests were used for detection of 
serum IgG antibodies to Anaplasma phagocytophilum, Babesia microti, Bartonella henselae/B. quintana, and 
Rickettsia helvetica/R. conorii. Because of substantial cross reactivity for IgG antibodies to Bartonella 
henselae/B. quintana and Rickettsia helvetica/R. conorii, the results are reported summarized for the Bartonella 
species and the Rickettsia species respectively. Analyzes and interpretation of results were performed according 
to the manufacturer's instructions. All samples were analyzed for IgG-antibodies to Bb. A portion of the samples 
were analyzed for IgG-antibodies to other tick-borne infections, these samples were collected consecutively from 
the start of the study. Further details on the serological test procedures have been published previously17.   
Questionnaire  
Participants were encouraged to answer the questionnaire online, but a paper version was also available on 
request. The questionnaire included questions about demographics, physical activity, exposure to tick-bites, 
previous tick-borne diseases, number of other diseases (0 - 22), Patient Health Questionnaire-15, Modern Health 
Worries-questionnaire 18 and Hospital Anxiety and Depression scale 19.  
The Patient Health Questionnaire-15 (PHQ-15) charts prevalence and intensity of 15 symptoms during the last 4 
weeks (www.phqscreeners.com), and the following sum score cut-off values have been stated for somatic 
symptom load; 0 - 4 points: normal, 5 - 9 points: mild, 10 - 14 points: moderate, 15 - 30 points: severe 20. In a 
systematic review of questionnaires, the PHQ-15 questionnaire was recommended for assessing somatic 
symptoms in large scale studies 21. The questionnaire has been validated in several studies and European 
languages 2,20,22, including Swedish.  
Sample size and statistics 
The hypothesis was that presence of serum IgG-antibodies to Bb is associated with increased somatic symptom 
load. Based on previous studies we assumed 20% prevalence of serum IgG-antibodies to Bb23, and proportions 
with moderate to severe somatic symptom load in the seropositive and seronegative groups to be 20% and 15%, 
respectively 24. On this background, a power- and sample size calculation (www.openepi.com) implied a 
required total sample size of 2832 to show an association between exposure to Bb-infection and moderate to 
severe somatic symptom load with 80% statistical power at a 5% significance level.  
We did a multivariable regression analysis to adjust for various factors with possible association with somatic 
symptom load. No further power calculation was performed prior to the multivariable regression analysis. We 
chose linear model rather than a logistic model to avoid loss of power in the statistical processing. P < 0.05 was 
considered statistically significant. Statistical analyzes were performed using SPSS version 25. 
Ethics  
The study was approved by the Regional Committee for Medical and Health Research Ethics (approval number 
2013/2082 and 2014/449), and the Research Unit at Sørlandet Hospital. All participants signed an informed 
consent, and they could withdraw their consent at any time. Seven randomly selected participants received a gift 




Study participants and recruitment rates 
Out of 7424 invited individuals, 3571 responded. Serum and questionnaires were available from 2968, and they 
were included in the study. Demographic data and recruitment rates according to gender and age are described in 
table 1. Mean age was 48.6 years (95% CI 48.1 - 49.0)  and the proportion of females was 54.6% (95% CI 52.8 - 
56.4) in the study participants versus 41.9 years and 48.8% in the whole Søgne population aged 18-69 years. 
Further demographic characteristics have been published previously 4. 
Exposure to tick-bites and tick-borne infections 
Self-reported exposure to tick-bites and tick-borne diseases are described in table 2. Health complaints attributed 
to tick-borne disease by the responders themselves, or their general practitioner, were reported by 5.0% (95% CI 
4.2 - 5.8) (147/2947). The prevalence of serum IgG-antibodies to different tick-borne pathogens are listed in 
table 3. Out of the 1058 responders tested for all six microbes, 5.7% (95% CI 4.3 - 7.1) (60/1058) were 
seropositive to at least two microbes. The prevalence of serum IgG-antibodies to Bb was higher among males 
than females (29.3% (394/1347) vs 17.6% (286/1621), difference 11.7% (95% CI 8.6 - 14.8)), and tended for 
both genders to increase with age. The seroprevalence of IgG-antibodies to Bb was 23.0% (283/1229) for 
samples tested to at least one other tick-borne pathogen than Bb, and 22.8% (397/1739) for samples tested only 
for Bb, difference 0.2% (95% CI -2.8 - 3.3). The prevalence of serum IgG-antibodies to Bb was 21.9% 
(267/1221) among participants recruited when visiting the general practitioner, and 22.9% (367/1606) among 
participants recruited by invitation, difference 1.0% (95% CI -2.1 - 4.1).   
Somatic symptom load 
PHQ-15 score was available for 2908 individuals. PHQ-15 mean score was 5.3 (95% CI 5.1-5.5). Moderate to 
severe somatic symptom load (i.e. PHQ-15 sum score > 10) was reported by 16.5% (95% CI 15.1 - 17.8) 
(479/2908) of the responders. The most frequent single complaints were feeling tired/having low energy, pain in 
arms/legs/joints, back pain, headache and trouble sleeping. PHQ-15 sum score > 10 was reported by 20.8% 
(248/1190) of the participants recruited when visiting the general practitioner’s center, and by 13.2% (210/1592) 
of those recruited by invitation letter/phone, difference 7.6% (95% CI 4.8 - 10.5). Further characteristics of the 
somatic symptom load have been published previously4. 
Somatic symptom load and exposure to tick-borne infections 
In univariable analysis (table 4) the prevalence of moderate to severe somatic symptom load was lower among 
individuals with serum IgG-antibodies to Bb than among individuals without. The prevalence of moderate to 
severe somatic symptom load was similar among individuals with serum IgG-antibodies to other tick-borne 
microbes than Bb and among individuals without.  
Table 5 shows how various variables differed in Bb IgG-antibody seropositive and seronegative/equivocal 
participants. When these variables and Bb antibody status were entered into a multivariable regression model, 
presence of serum IgG-antibodies to Bb was not associated with somatic symptom load (table 6). In the 
multivariable model the following variables were associated with increased somatic symptom load: Anxiety and 
depression, number of other diseases, female gender, younger age, recruitment when attending the general 
practitioner’s office, < 6 years education after primary school, tick-bite earlier in life, erythema migrans earlier in 
life, less physical activity, and modern health worries (table 6). R2 for the multivariable regression analysis was 
0.393.  Presence of IgG-antibodies to other tick-borne microbes than Bb, or seropositivity to at least two 
microbes, were not associated with somatic symptom load when entered in a multivariable regression model 
with other independent variables as listed in table 6 (data not shown, n = 1031).  
Discussion  
The main result of our study is that presence of serum IgG-antibodies to Borrelia burgdorferi sensu lato, Tick-
borne encephalitis virus, Anaplasma phagocytophilum, Babesia microti, Bartonella henselae/B. quintana and 
Rickettsia helvetica/R. conorii were not associated with increased self-reported somatic symptom load. Neither 
was simultaneous seropositivity to at least two microbes. Also in previous studies exploring the association 
between IgG-antibodies to Bb and health complaints, no association was found 25,26. However, these studies 
evaluated only serum IgG-antibodies to Bb, and in one 26, the participants were blood donors that might be a 
group with less health complaints than the general population.  
Strengths of our study is the large number of participants from the general adult population, and that all serum 
samples were tested for IgG-antibodes to Bb. Weaknesses are potential biases as analysis of IgG-antibodies to 
other tick-borne microbes than Bb only in a selected portion, different recruitment strategies during the study-
period, and higher mean age and a larger proportion of women in the study-population than in the whole Søgne 
population aged 18-69 years. However, the seroprevalence of IgG-antibodies to Bb did not differ between the 
group of samples tested only for Bb, and the group of samples tested for other tick-borne microbes. We therefore 
consider the selection of samples tested for antibodies to other microbes than Bb as serological representative. 
Most of the participants were recruited by invitation letter/phone, or when visiting the general practitioner’s 
center. The participants recruited when visiting the general practitioner’s center reported higher somatic 
symptom load than those recruited by invitation, but the seroprevalence of IgG-antibodies to Bb did not differ 
between these groups. Although if the recruitment procedure may have caused an overestimation of health 
complaints in the population, we will not expect such a bias to influence the association between presence of 
antibodies to tick-borne microbes and self-reported somatic symptom load. The skewed age and gender 
distribution in our sample may also have caused a bias since seroprevelence of IgG-antibodies to tick-borne 
pathogens and PHQ-15 score both show variation according to age and gender groups4,17. These factors are 
therefore adjusted for in the multivariable regression model.    
In the regression analyses, self-reported exposure to tick-bite earlier in life, and erythema migrans earlier in life, 
were both weakly associated with increased somatic symptom load. This result is in contrast to a previous 
Norwegian study of blood donors in a region with somewhat lower prevalence of tick-borne infections, were no 
association between self-reported exposure to tick-bite and load of subjective health complaints was found 26. 
Possible explanations for this discrepancy may be a greater tendency to attribute present somatic symptoms to 
previous tick-borne diseases in our high endemic region, or/and an overrepresentation in the study of individuals 
who attribute their symptoms to assumed tick-borne disease. A recall bias regarding exposure to tick-bite (and 
tick-borne diseases) more than one year ago can also be present since reporting tick-bite the last year was not 
associated with increased somatic symptom load. However, we cannot completely exclude that the association 
between reporting exposure to tick-bite or/and erythema migrans earlier in life, and increased somatic symptom 
load, may be due to previous tick-borne diseases not identified by the serological testing. 
In conclusion, our study showed no association between presences of serum IgG-antibodies to tick-borne 
microbes and self-reported somatic symptom load. Although there was a weak association between self-reported 
somatic symptom load and self-reported previous exposure to tick-bites and erythema migrans, the result of our 
study does not support the hypothesis claiming a causal connection between tick-borne diseases and subjective 
health complaints.  
References 
1. Wilhelmsen I, Mulindi S, Sankok D, Wilhelmsen AB, Eriksen HR, Ursin H. Subjective health 
complaints are more prevalent in Maasais than in Norwegians. Nord J Psychiatry. 
2007;61(4):304-309. 
2. Kocalevent RD, Hinz A, Brahler E. Standardization of a screening instrument (PHQ-15) for 
somatization syndromes in the general population. BMC Psychiatry. 2013;13:91. 
3. Hinz A, Ernst J, Glaesmer H, et al. Frequency of somatic symptoms in the general population: 
Normative values for the Patient Health Questionnaire-15 (PHQ-15). J Psychosom Res. 
2017;96:27-31. 
4. Thortveit ET, Lorentzen AR, Ljostad U, Mygland A. Somatic symptoms and fatigue in a 
Norwegian population with high exposure to ticks. Ticks Tick Borne Dis. 2019;10(1):156-161. 
5. Haller H, Cramer H, Lauche R, Dobos G. Somatoform disorders and medically unexplained 
symptoms in primary care. Dtsch Arztebl Int. 2015;112(16):279-287. 
6. Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: an epidemiological 
study in seven specialities. J Psychosom Res. 2001;51(1):361-367. 
7. Stone J, Carson A, Duncan R, et al. Symptoms 'unexplained by organic disease' in 1144 new 
neurology out-patients: how often does the diagnosis change at follow-up? Brain. 
2009;132(Pt 10):2878-2888. 
8. Berende A, ter Hofstede HJ, Vos FJ, et al. Randomized Trial of Longer-Term Therapy for 
Symptoms Attributed to Lyme Disease. N Engl J Med. 2016;374(13):1209-1220. 
9. Haahr R, Tetens MM, Dessau RB, et al. Risk of neurological disorders in patients with 
European Lyme neuroborreliosis. A nationwide population-based cohort study. Clin Infect 
Dis. 2019. 
10. Jore S, Viljugrein H, Hofshagen M, et al. Multi-source analysis reveals latitudinal and 
altitudinal shifts in range of Ixodes ricinus at its northern distribution limit. Parasit Vectors. 
2011;4:84. 
11. Eliassen KE, Berild D, Reiso H, et al. Incidence and antibiotic treatment of erythema migrans 
in Norway 2005-2009. Ticks Tick Borne Dis. 2017;8(1):1-8. 
12. Michelet L, Delannoy S, Devillers E, et al. High-throughput screening of tick-borne pathogens 
in Europe. Front Cell Infect Microbiol. 2014;4:103. 
13. Quarsten H, Skarpaas T, Fajs L, Noraas S, Kjelland V. Tick-borne bacteria in Ixodes ricinus 
collected in southern Norway evaluated by a commercial kit and established real-time PCR 
protocols. Ticks Tick Borne Dis. 2015;6(4):538-544. 
14. Stensvold CR, Al Marai D, Andersen LO, et al. Babesia spp. and other pathogens in ticks 
recovered from domestic dogs in Denmark. Parasit Vectors. 2015;8:262. 
15. Karlsson ME, Andersson MO. Babesia species in questing Ixodes ricinus, Sweden. Ticks Tick 
Borne Dis. 2016;7(1):10-12. 
16. Ljostad U, Mygland A, Skarpaas T. [Neuroborreliosis in Vest-Agder]. Tidsskr Nor Laegeforen. 
2003;123(5):610-613. 
17. Thortveit ET, Aase A, Petersen LB, Lorentzen AR, Mygland A, Ljostad U. Human 
seroprevalence of antibodies to tick-borne microbes in southern Norway. Ticks Tick Borne 
Dis. 2020:101410. 
18. Indregard AM, Ihlebaek CM, Eriksen HR. Modern health worries, subjective health 
complaints, health care utilization, and sick leave in the Norwegian working population. Int J 
Behav Med. 2013;20(3):371-377. 
19. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and 
Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69-77. 
20. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the 
severity of somatic symptoms. Psychosom Med. 2002;64(2):258-266. 
21. Zijlema WL, Stolk RP, Lowe B, Rief W, White PD, Rosmalen JG. How to assess common 
somatic symptoms in large-scale studies: a systematic review of questionnaires. J Psychosom 
Res. 2013;74(6):459-468. 
22. Nordin S, Palmquist E, Nordin M. Psychometric evaluation and normative data for a Swedish 
version of the Patient Health Questionnaire 15-Item Somatic Symptom Severity Scale. Scand J 
Psychol. 2013;54(2):112-117. 
23. Mygland A, Skarpaas T, Ljostad U. Chronic polyneuropathy and Lyme disease. Eur J Neurol. 
2006;13(11):1213-1215. 
24. Ihlebaek C, Eriksen HR, Ursin H. Prevalence of subjective health complaints (SHC) in Norway. 
Scand J Public Health. 2002;30(1):20-29. 
25. Grabe HJ, Spitzer C, Ludemann J, et al. No association of seropositivity for anti-Borrelia IgG 
antibody with mental and physical complaints. Nord J Psychiatry. 2008;62(5):386-391. 
26. Hjetland R, Reiso H, Ihlebaek C, Nilsen RM, Grude N, Ulvestad E. Subjective health complaints 
are not associated with tick bites or antibodies to Borrelia burgdorferi sensu lato in blood 

























































   
All participants  2968 40.0 
Gender    
Male  1347 (45.4) 35.4 




18-29 275 (9.3) 14.6 
30-39  491 (16.5) 35.9 
40-49  736 (24.8) 43.9 
50-59  709 (23.9) 51.1 




Invitation  1606 (54.1)  




141 (4.8)  
Partner 2287 (77.1)  
Children  1294 (43.6)  
Alone  392 (13.2)  
 
Education after primary 
school  
  
< 3 years  1097 (37.0)  
> 3 - < 6 years 1117 (37.6)  





> 20 000 NOK 2606 (87.8)  
   










Tick-bite earlier in life 
 
85.1 (83.8 - 86.4) 
 
2508/2947 
Three or more tick-bites earlier in life 63.9 (62.2 - 65.6) 1883/2947 
Tick-bite the last year 33.4 (31.7 - 35.2) 984/2942 
EM earlier in life 24.6 (23.0 - 26.1) 723/2942 


































Borrelia burgdorferi sensu lato 
 
22.9 (21.4 - 24.4) 
 
680/2968 
Tick-borne encephalitis virusb 3.2 (2.2 - 4.2) 37/1164 
Anaplasma phagocytophilum 10.8 (9.0 - 12.5) 125/1162 
Babesia microti 2.1 (1.3 - 2.9) 26/1229 
Bartonella henselae or/and B. quintana 0.2 (0.0 - 0.4) 2/1162 
Rickettsia helvetica or/and R. conorii 4.1 (2.9 - 5.2) 47/1157 
 
aAll 2968 samples were analyzed for antibodies to Bb, and 1157 - 1229 samples for antibodies to the other 
pathogenes, bPrevalence 1.4 % (95% CI 0.3 - 2.6) (6/419) when assessing only participants not reporting being 


















Table 4: Proportion with PHQ-15 sum score > 10 according to prevalence of serum IgG antibodies to different 














% (95% CI) 
 
IgG 
seropositive   
 
 
IgG seronegative  
or equivocal  
 
 
Borrelia burgdorferi sensu lato 12.5 (83/665) 
 
17.7 (396/2243) 5.2 (2.1 - 8.0) 
Tick-borne encephalitis virus 22.2 (8/36) 
 
20.0 (219/1094) 2.2 (-8.6 - 18.2) 
Anaplasma phagocytophilum 17.4 (21/121) 
 
19.5 (197/1009) 2.1 (-6.0 - 8.4) 
Babesia microti 19.2 (5/26) 
 
19.9 (233/1169) 0.7 (-18.1 - 11.7) 
Bartonella henselae or/and B. quintana  0 (0/2) 
 
20.1 (226/1126) 20.1 (-45.7 - 22.5) 
Rickettsia helvetica or/and R. conorii 24.4 (11/45) 
 
19.8 (214/1079) 4.6 (-5.9 - 19.0) 
> 2 out of the 6 tested pathogens 13.3 (8/60) 19.7 (197/998) 6.4 (-4.7 - 13.3) 


















Bb IgG seronegative 




groups (95% CI) 
Male gender (%) 57.9  41.7  16.2 (11.9 - 20.4) 
Age (mean years) 53.1  47.2  5.9 (4.8 - 7.0) 
Recruitment GP (%) 39.3  41.7  2.4 (-1.8 - 6.5) 
Number of diseases (mean) 1.0  1.0  0.0 (-0.1 - 0.1) 
Living alone (%) 
Education after primary school > 6 years (%) 
Net household income 
 > 20 000 NOK/month (%) 
 











0.1 (-3.0 - 2.9) 
1.5 (-2.0 - 5.2) 
3.1 (0.3 - 5.5) 
 
6.0 (2.8 - 9.4) 
Tick bite earlier in life (%) 91.3  83.3  8.0 (5.2 - 10.5) 
Tick-bite the last year (%) 





15.3 (11.5 - 19.2) 
10.6 (6.7 - 14.6) 
Modern health worries scale score (mean) 2.0  2.0  0.0 (-0.1 - 0.1) 
Hospital anxiety and depression  
scale sum score (mean) 
 
7.1  7.7  0.7 (0.1 - 1.2) 
    









Table 6: Linear regression with PHQ-15 sum score as dependent variablea  
 
 








Anxiety and depressionb  0.283 0.371 <0.001 
Number of diseasesc  1.040 0.271 <0.001 
Male gender  -1.677 -0.181 <0.001 
Age (years)   -0.041 -0.117 <0.001 
Recruitment GPd  0.835 0.089 <0.001 
Education after primary school < 3 years 0.168 0.018 0.287 
 > 6 years -0.656 -0.059 <0.001 
 Unknown 0.137 0.005 0.757 
Tick bite earlier in life  0.733 0.056 <0.001 
Erythema migrans earlier in life  0.409 0.038 0.014 
Physical activitye  -0.175 -0.032 0.031 
Modern health worriesf  0.006 0.031 0.046 
Borrelia IgG seropositive  -0.257 -0.024 0.125 
Net household incomeg  -0.181 -0.016 0.343 
Tick-bite the last year  -0.038 -0.004 0.807 
Living alone  0.020 0.001 0.928 
     
 
an = 2846, bHospital Anxiety and Depression scale sum score, cNumber of diseases reported by the participant, 
dRecruited when visiting the GP center, eMean hours physical activity/week (< 1 / > 1 - < 3/ > 3 - < 6 / > 6), 
fModern Health Worries questionnaire sum score, gNet household income/month (NOK < 10 000 / 10 000 - 
20 000 / >20 000). Abbreviations: PHQ-15: Patent Health Questionnaire-15, B: Regression coefficient, GP: 
General Practitioner 
 
 
 
 
 
 
 
